PMIVX Mutual Fund

NAV$11.56

Fund Essentials - as of Feb 28, 2026

Net Assets
-
Expense Ratio
0.48%
Dividend Yield (Current)
3.92%
Holdings
1,942
Inception Date
Feb 10, 2023
Fund Family
Franklin Templeton Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Monthly
SEC 30-Day Yield
PRO

Performance

YTD+1.94%
1 Year+11.78%
3 Year+10.62%

Asset Allocation

Stocks: 32.59%
Bonds: 67.14%
Other: 0.27%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
-Umbs 30Yr Tba(Reg A) 5.5% Mar 13, 20234.29%
-Fannie Mae Pool 0.06% Mar 13/20531.68%
NVDANvidia Corp.1.66%
AAPLApple, Inc1.57%
-Fannie Mae Or Freddie Mac Tba, 2%, Due 08/01/20501.47%
Top 10 Concentration: 16.10%Report Date: Feb 28, 2026
Download all 1942 holdings for PMIVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.92%
Frequency
Monthly

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how PMIVX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

PMIVX Mutual Fund Overview

PMIVX Mutual Fund (Franklin Multi-Asset Income Fund Class R6) is managed by Franklin Templeton Investments (US). PMIVX expense ratio is 0.48%, holding 1942 positions across sectors including Other, Financials, Information Technology. Inception date: 2023-02-10.

PMIVX performance shows a YTD return of 1.94%. The 1-year return is 11.78%. PMIVX dividend yield stands at 3.92%, paid monthly.

PMIVX top holdings include Umbs 30Yr Tba(Reg A) 5.5% Mar 13, 2023 (4.3%), Fannie Mae Pool 0.06% Mar 13/2053 (1.7%), Nvidia Corp. (1.7%), Apple, Inc (1.6%), Fannie Mae Or Freddie Mac Tba, 2%, Due 08/01/2050 (1.5%). View all PMIVX holdings, sector breakdown, or dividend history.

PMIVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PMIVX alternatives are available via the screener, along with tax-loss harvesting opportunities.